Jointly provided by:	This activity is supported by independent educational grants from Baxalta US, Inc., Bayer HealthCare Pharmaceuticals Inc., Biogen, Emergent BioSolutions Inc., Grifols, and Novo Nordisk, Inc.
Wednesday, October 28, 2015. 6:00 AM - 8:00 AM ET Gaylord Palms Hotel & Convention Center Room Osceola A Orlando, FL Please note: No additional fee is required to attend this CME/CPE activity; however, registration to AMCP Nexus 2015 is required.	Held in conjunction with AMCP Nexus 2015.
Click here to download the slides from this symposium.
Hot Topics Include: The evolving managed care and specialty pharmacy landscape An advanced review of inhibitors and prophylaxis treatment Tools and resources to document outcomes of payer and specialty pharmacy hemophilia management HTC, managed care, and specialty pharmacy collaboration (case-based presentations)
Distinguished Faculty Presenters
Jonathan Roberts, MD Hematologist Assistant Research Director Bleeding & Clotting Disorders Institute Celynda G. Tadlock, PharmD, MBA Vice President, Pharmacy Business Development Aetna Michael Zeglinski, RPh Senior Vice President, Specialty Pharmacy OptumRx®/BriovaRx®
Who Should Attend? This activity is designed to meet the educational needs of managed care pharmacy directors, clinical pharmacists, quality directors, medical directors, members of AMCP, and other managed health care professionals attending AMCP Nexus 2015. Statement of Need/Program Overview Hemophilia is an expensive chronic condition with total annual costs that can average $250,000 or more for severe patients. Optimal outcomes requires a collaborative and coordinated patient experience. The collaborative team can include an insurer, Hemophilia Treatment Center (HTC), and specialty pharmacy. Specialty pharmacy services can support patient adherence to treatment and assist physicians, plans, and employers in meeting clinical and/or financial goals. This symposium, jointly provided by the National Hemophilia Foundation, will emphasize the need for well-coordinated treatment management, the importance of understanding effective ways of using available treatments, and the importance of collaboration among all stakeholders. Educational Objectives After completing this activity, the participant should be better able to: Describe current and evolving strategies used by managed care organizations (MCOs) and specialty pharmacy providers to facilitate high quality care for members with hemophilia Summarize the most recent clinical recommendations for the treatment of patients with hemophilia, including prophylactic factor replacement Explain the severe complication of hemophilia treatment known as inhibitor development, including its significant clinical and economic consequences Utilize processes for MCOs and specialty pharmacy providers to improve communications with HTCs Apply collaborative methods that enable the benefits of the comprehensive care model provided by HTCs to be realized by multiple hemophilia stakeholders including MCOs and specialty pharmacy providers Provide accurate and appropriate counsel as part of the managed care treatment team
Date and Time Wednesday, October 28, 2015 6:00 AM - 8:00 AM Gaylord Palms Hotel & Convention Center Room Osceola A Orlando, FL Agenda 6:00 AM Breakfast and Registration 6:05 AM Pre-Activity Learning Assessment and Opening Comments 6:15 AM The Evolving Managed Care and Specialty Pharmacy Landscape Celynda G. Tadlock, PharmD, MBA 6:40 AM An Advanced Review of Inhibitors and Prophylaxis Treatment Jonathan Roberts, MD 7:10 AM Measuring Success: Tools and Resources to Document Outcomes of Payer and Specialty Pharmacy Hemophilia Management Michael Zeglinski, RPh 7:25 AM HTC, Managed Care, and Specialty Pharmacy Collaboration Faculty Panel 7:40 AM Moderated Faculty Panel Discussion and Audience Q&A 7:55 AM Closing Comments Post-Activity Assessment and Evaluation
Physician Continuing Medical Education Accreditation Statement This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine, the National Hemophilia Foundation, and Impact Education, LLC. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians. Credit Designation Postgraduate Institute for Medicine designates this live activity for a maximum of 2.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Pharmacist Continuing Education Accreditation Statement Postgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Credit Designation Postgraduate Institute for Medicine designates this continuing education activity for 2.0 contact hours (0.20 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - (0809-9999-15-255-L01-P) Type of Activity: Application For Pharmacists: Upon receipt of a completed activity evaluation form, you will receive an email from the Postgraduate Institute for Medicine within 3 weeks with a link and directions to submit your credit to the NABP CPE Monitor Service.
Disclosure of Conflicts of Interest Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity. Americans with Disabilities Act Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Impact Education, LLC, prior to the live event at (215) 619-8812. Fee Information No additional fee is required to attend this CPE/CME activity. Please note: No additional fee is required to attend this CME/CPE activity; however, registration to AMCP Nexus 2015 is required. Pre-registration will close at 12:00 pm on October 27, 2015. Walk-in registration will be available at the time of the program. If you have any questions, please call (215) 619-8812 or email info@impactedu.net.